Clinical Trials

Study Title:
A Phase II Randomized Trial of Adjuvant Therapy With Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma With High Risk Features

For more information about the trial above please contact the study team: Medical University of South Carolina Principal Investigator, Jennifer Harper, at harperjl@musc.edu. Study Coordinator, Madison Avinger, at avingerm@musc.edu. Trial opened at the following institutions: Medical University of South Carolina